SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-015281
Filing Date
2023-04-27
Accepted
2023-04-27 16:13:51
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A amlx-defa14a-2023-additi.htm DEFA14A 40348
2 GRAPHIC img43653419_0.jpg GRAPHIC 419540
3 GRAPHIC img43653419_1.jpg GRAPHIC 387134
  Complete submission text file 0000950170-23-015281.txt   1151998
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41199 | Film No.: 23857036
SIC: 2834 Pharmaceutical Preparations